Clinical trial
Study Evaluating Sirolimus in Kidney Transplant Recipients
NCT00195273 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00195273 |
|---|---|
| Title | Study Evaluating Sirolimus in Kidney Transplant Recipients |
| Official title | A Randomized Open-Label Study Comparing the Efficacy and Safety of Sirolimus Combined With Daclizumab, Mycophenolate and Corticosteroids vs Cyclosporine, Mycophenolate and Corticosteroids in Renal Allograft Recipients Receiving Kidneys From Older Donors |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Graft vs Host Disease, Kidney Transplantation |
| Intervention type | Drug |
| Interventions | sirolimus, cyclosporine, mycophenolate mofetil, corticosteroids, daclizumab |
| Enrollment | 61 |
| Start date | Nov 1, 2004 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Sep 19, 2005 |
| Last update posted | Apr 28, 2010 |
| Countries | Norway, Sweden |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: